Athena Countouriotis
Direktor/Vorstandsmitglied bei BIOMARIN PHARMACEUTICAL INC.
Vermögen: 23 058 $ am 30.04.2024
Aktive Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Jean-Jacques Bienaimé | M | 70 | 19 Jahre | |
| Asa Abeliovich | M | 60 |
Leal Therapeutics, Inc.
 Leal Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Leal Therapeutics, Inc. develops novel therapeutics for patients with major disorders of the central nervous systems. | - |
| Frederick Vogt | M | 50 | 8 Jahre | |
| Edgar Cale | M | 60 | 5 Jahre | |
| William Chou | M | 51 | 2 Jahre | |
| Gini Deshpande | M | - |
NuMedii, Inc.
 NuMedii, Inc. Miscellaneous Commercial ServicesCommercial Services NuMedii, Inc. discovers and de-risks effective new drugs by translating Life Sciences Big Data into therapies. Its Big Data technology, originally developed at Stanford University, utilizes large amounts of scientific data together with proprietary biological network-based algorithms to discover drug-disease connections and biomarkers that are predictive of efficacy. The firm translates these predictions into novel de-risked drug candidates and partners with pharmaceutical companies for development and commercialization. The company was founded by Gini Deshpande, Joel Dudley and Atul J. Butte in 2008 and is headquartered in Palo Alto, CA. | 16 Jahre |
| Maxine Gowen | M | 66 | 3 Jahre | |
| Liam Ratcliffe | M | 60 |
Recludix Pharma, Inc.
 Recludix Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services Recludix Pharma, Inc. is a biotechnology company that develops platform approaches to discover potent and selective inhibitors of challenging protein targets. The company is based in San Diego, CA. The company was founded by Brian Hodous, Nicholas B. Lydon, Patrick P. Zarrinkar, Daniel K. Treiber. Nancy C. Whiting has been the CEO of the company since 2021. | 5 Jahre |
| Patrick P. Zarrinkar | M | - |
Recludix Pharma, Inc.
Recludix Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services Recludix Pharma, Inc. is a biotechnology company that develops platform approaches to discover potent and selective inhibitors of challenging protein targets. The company is based in San Diego, CA. The company was founded by Brian Hodous, Nicholas B. Lydon, Patrick P. Zarrinkar, Daniel K. Treiber. Nancy C. Whiting has been the CEO of the company since 2021. | - |
| Jean-Marc Bellemin | M | 51 | 4 Jahre | |
| Laura Shawver | M | 66 |
Capstan Therapeutics, Inc.
 Capstan Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Capstan Therapeutics, Inc. is a biotechnology company that develops targeted in vivo RNA technologies to multiply therapeutic possibilities for patients. Capstan Therapeutics is based in San Diego, CA. The company's platform technology, tLNPs, delivers payloads capable of reprogramming specific cell types in vivo, including gene editing tools. The company aims to generate transformative therapies for autoimmune disorders, oncology, fibrosis, and monogenic blood disorders. The company was founded in 2022 by Haig Aghajanian, and the CEO is Laura K. Shawver. | - |
| Alexander Hardy | M | 56 | 1 Jahre | |
| Jeffrey Henderson | M | 59 | 9 Jahre | |
| Randy Meier | M | 65 | 18 Jahre | |
| Merrill McPeak | M | 88 | 13 Jahre | |
| Willard Dere | M | 70 | 8 Jahre | |
| Atul J. Butte | M | - |
NuMedii, Inc.
NuMedii, Inc. Miscellaneous Commercial ServicesCommercial Services NuMedii, Inc. discovers and de-risks effective new drugs by translating Life Sciences Big Data into therapies. Its Big Data technology, originally developed at Stanford University, utilizes large amounts of scientific data together with proprietary biological network-based algorithms to discover drug-disease connections and biomarkers that are predictive of efficacy. The firm translates these predictions into novel de-risked drug candidates and partners with pharmaceutical companies for development and commercialization. The company was founded by Gini Deshpande, Joel Dudley and Atul J. Butte in 2008 and is headquartered in Palo Alto, CA. | 16 Jahre |
| Kathleen Borthwick | F | 48 | 3 Jahre | |
| Karen Smith | F | - |
Capstan Therapeutics, Inc.
Capstan Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Capstan Therapeutics, Inc. is a biotechnology company that develops targeted in vivo RNA technologies to multiply therapeutic possibilities for patients. Capstan Therapeutics is based in San Diego, CA. The company's platform technology, tLNPs, delivers payloads capable of reprogramming specific cell types in vivo, including gene editing tools. The company aims to generate transformative therapies for autoimmune disorders, oncology, fibrosis, and monogenic blood disorders. The company was founded in 2022 by Haig Aghajanian, and the CEO is Laura K. Shawver. | - |
| Dennis Joseph Slamon | M | 75 | 10 Jahre | |
| Daniel K. Treiber | M | - |
Recludix Pharma, Inc.
Recludix Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services Recludix Pharma, Inc. is a biotechnology company that develops platform approaches to discover potent and selective inhibitors of challenging protein targets. The company is based in San Diego, CA. The company was founded by Brian Hodous, Nicholas B. Lydon, Patrick P. Zarrinkar, Daniel K. Treiber. Nancy C. Whiting has been the CEO of the company since 2021. | - |
| Nancy Whiting | M | 51 |
Recludix Pharma, Inc.
Recludix Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services Recludix Pharma, Inc. is a biotechnology company that develops platform approaches to discover potent and selective inhibitors of challenging protein targets. The company is based in San Diego, CA. The company was founded by Brian Hodous, Nicholas B. Lydon, Patrick P. Zarrinkar, Daniel K. Treiber. Nancy C. Whiting has been the CEO of the company since 2021. | 3 Jahre |
| Elizabeth Anderson | F | 66 | 5 Jahre | |
| Sara Pellegrino | F | - | - | |
| James M. Wilson | M | - | 7 Jahre | |
| Derrell Porter | M | 53 | 3 Jahre | |
| Barbara Bodem | F | 56 | 1 Jahre | |
| Stuart M. Henderson | M | - | 3 Jahre | |
| Haig Aghajanian | M | - |
Capstan Therapeutics, Inc.
Capstan Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Capstan Therapeutics, Inc. is a biotechnology company that develops targeted in vivo RNA technologies to multiply therapeutic possibilities for patients. Capstan Therapeutics is based in San Diego, CA. The company's platform technology, tLNPs, delivers payloads capable of reprogramming specific cell types in vivo, including gene editing tools. The company aims to generate transformative therapies for autoimmune disorders, oncology, fibrosis, and monogenic blood disorders. The company was founded in 2022 by Haig Aghajanian, and the CEO is Laura K. Shawver. | 2 Jahre |
| Brian Hodous | M | - |
Recludix Pharma, Inc.
Recludix Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services Recludix Pharma, Inc. is a biotechnology company that develops platform approaches to discover potent and selective inhibitors of challenging protein targets. The company is based in San Diego, CA. The company was founded by Brian Hodous, Nicholas B. Lydon, Patrick P. Zarrinkar, Daniel K. Treiber. Nancy C. Whiting has been the CEO of the company since 2021. | - |
| Sandipkumar S. Kapadia | M | 54 | 5 Jahre | |
| David Pyott | M | 70 | 8 Jahre | |
| Philip Lo Scalzo | M | - | 17 Jahre | |
| Mark Alles | M | 64 | 2 Jahre | |
| Elaine Heron | M | 76 | 22 Jahre | |
| V. Lawlis | M | 72 | 17 Jahre | |
| May Kin Ho | M | 71 | 3 Jahre | |
| Michael Weiser | M | 61 | 6 Jahre | |
| Brian Mueller | M | 50 | 22 Jahre | |
| Wayne P. Rothbaum | M | 56 | 8 Jahre | |
| Wendy Yarno | F | 69 | 1 Jahre | |
| Mark Enyedy | M | 60 | 1 Jahre | |
| Ryan Maynard | M | 54 | 9 Jahre | |
| Iain Dukes | M | 65 | 8 Jahre | |
| George Davis | M | 53 | 20 Jahre | |
| Stuart Bunting | M | - | 16 Jahre | |
| Jeff Ajer | M | 61 | 19 Jahre | |
| Mohammad Hirmand | M | 54 |
Avenzo Therapeutics, Inc.
 Avenzo Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Avenzo Therapeutics, Inc. is a biotechnology company that operates in the field of therapeutics. The company is based in San Diego, CA. The company was founded by Mohammad Hirmand and the CEO is Athena M. Countouriotis. | - |
| Saqib Islam | M | 54 | 5 Jahre | |
| Robert Hombach | M | 58 | 7 Jahre | |
| Tracy Winton | F | - | 4 Jahre | |
| Henry Fuchs | M | 66 | 15 Jahre | |
| Andrea Campanile | F | - | - | |
| Rajul Jain | F | - |
Capstan Therapeutics, Inc.
Capstan Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Capstan Therapeutics, Inc. is a biotechnology company that develops targeted in vivo RNA technologies to multiply therapeutic possibilities for patients. Capstan Therapeutics is based in San Diego, CA. The company's platform technology, tLNPs, delivers payloads capable of reprogramming specific cell types in vivo, including gene editing tools. The company aims to generate transformative therapies for autoimmune disorders, oncology, fibrosis, and monogenic blood disorders. The company was founded in 2022 by Haig Aghajanian, and the CEO is Laura K. Shawver. | - |
| Marni Kottle | F | - | - | |
| Ganesh Vedantham | M | - | 3 Jahre | |
| Erin Burkhart | F | 45 | 2 Jahre | |
| Andrew Levin | M | - |
Capstan Therapeutics, Inc.
Capstan Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Capstan Therapeutics, Inc. is a biotechnology company that develops targeted in vivo RNA technologies to multiply therapeutic possibilities for patients. Capstan Therapeutics is based in San Diego, CA. The company's platform technology, tLNPs, delivers payloads capable of reprogramming specific cell types in vivo, including gene editing tools. The company aims to generate transformative therapies for autoimmune disorders, oncology, fibrosis, and monogenic blood disorders. The company was founded in 2022 by Haig Aghajanian, and the CEO is Laura K. Shawver. | - |
| Humaira Serajuddin | F | - | 2 Jahre | |
| Rajul Jain | M | - |
Capstan Therapeutics, Inc.
Capstan Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Capstan Therapeutics, Inc. is a biotechnology company that develops targeted in vivo RNA technologies to multiply therapeutic possibilities for patients. Capstan Therapeutics is based in San Diego, CA. The company's platform technology, tLNPs, delivers payloads capable of reprogramming specific cell types in vivo, including gene editing tools. The company aims to generate transformative therapies for autoimmune disorders, oncology, fibrosis, and monogenic blood disorders. The company was founded in 2022 by Haig Aghajanian, and the CEO is Laura K. Shawver. | - |
| Amy Wireman | F | - | 11 Jahre | |
| C. Guyer | M | 62 | 4 Jahre | |
| Friedrich Finckenstein | M | 51 | 5 Jahre | |
| Nandita Shangari | M | 43 |
Capstan Therapeutics, Inc.
Capstan Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Capstan Therapeutics, Inc. is a biotechnology company that develops targeted in vivo RNA technologies to multiply therapeutic possibilities for patients. Capstan Therapeutics is based in San Diego, CA. The company's platform technology, tLNPs, delivers payloads capable of reprogramming specific cell types in vivo, including gene editing tools. The company aims to generate transformative therapies for autoimmune disorders, oncology, fibrosis, and monogenic blood disorders. The company was founded in 2022 by Haig Aghajanian, and the CEO is Laura K. Shawver. | - |
| Traci McCarty | F | - | - | |
| Brinda Balakrishnan | M | 44 | 8 Jahre | |
| Brad Glasscock | M | - | 12 Jahre | |
| Dave Jacoby | M | - | 8 Jahre | |
| Ted Driscoll | M | 71 |
NuMedii, Inc.
NuMedii, Inc. Miscellaneous Commercial ServicesCommercial Services NuMedii, Inc. discovers and de-risks effective new drugs by translating Life Sciences Big Data into therapies. Its Big Data technology, originally developed at Stanford University, utilizes large amounts of scientific data together with proprietary biological network-based algorithms to discover drug-disease connections and biomarkers that are predictive of efficacy. The firm translates these predictions into novel de-risked drug candidates and partners with pharmaceutical companies for development and commercialization. The company was founded by Gini Deshpande, Joel Dudley and Atul J. Butte in 2008 and is headquartered in Palo Alto, CA. | - |
| Kevin Eggan | M | - | 4 Jahre | |
| Alex Fotopoulos | M | 55 | 5 Jahre | |
| Igor Bilinsky | M | 51 | 3 Jahre | |
| Erez Chimovits | M | 60 |
Capstan Therapeutics, Inc.
Capstan Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Capstan Therapeutics, Inc. is a biotechnology company that develops targeted in vivo RNA technologies to multiply therapeutic possibilities for patients. Capstan Therapeutics is based in San Diego, CA. The company's platform technology, tLNPs, delivers payloads capable of reprogramming specific cell types in vivo, including gene editing tools. The company aims to generate transformative therapies for autoimmune disorders, oncology, fibrosis, and monogenic blood disorders. The company was founded in 2022 by Haig Aghajanian, and the CEO is Laura K. Shawver. | - |
| Eduardo Von Pervieux | M | - | 16 Jahre | |
| Michael Baran | M | - |
Capstan Therapeutics, Inc.
Capstan Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Capstan Therapeutics, Inc. is a biotechnology company that develops targeted in vivo RNA technologies to multiply therapeutic possibilities for patients. Capstan Therapeutics is based in San Diego, CA. The company's platform technology, tLNPs, delivers payloads capable of reprogramming specific cell types in vivo, including gene editing tools. The company aims to generate transformative therapies for autoimmune disorders, oncology, fibrosis, and monogenic blood disorders. The company was founded in 2022 by Haig Aghajanian, and the CEO is Laura K. Shawver. | 2 Jahre |
| Jen Saunders | F | - | 3 Jahre |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Bill Welch | M | 62 | 2 Jahre | |
| Amber Salzman | M | 62 | 2 Jahre | |
| Timothy Morris | M | 61 | 3 Jahre | |
| Stephen P. Squinto | M | 67 | 4 Jahre | |
| Kathryn Falberg | F | 63 | 9 Jahre | |
| Bruce Goldsmith | M | 58 | 2 Jahre | |
| David Ramsay | M | 59 | 12 Jahre | |
| Michael Swartzburg | M | 57 | 3 Jahre | |
| Steven Schwartz | M | 62 | 11 Jahre | |
| Harry Leonhardt | M | 67 | 5 Jahre | |
| Maria Fardis | M | 56 | 5 Jahre | |
| Samuel Barone | M | 51 | 3 Jahre | |
| Michael E. Paolucci | M | 64 | 5 Jahre | |
| Jean Bizzari | M | 69 | 9 Jahre | |
| Patrick Heron | M | 53 | 3 Jahre | |
| Jim Mazzola | M | - | 3 Jahre | |
| Thomas Woiwode | M | 52 | 5 Jahre | |
| Robert Engler | M | 79 | 11 Jahre | |
| Tadataka Yamada | M | 77 | 4 Jahre | |
| John Stuart Patton | M | 77 | 25 Jahre | |
| Eric Carter | M | 72 | 4 Jahre | |
| Alan Fuhrman | M | 67 | 4 Jahre | |
| Homa Yeganegi | F | - | - |
Statistik
| Land | Beziehungen | % des Gesamten |
|---|---|---|
| Vereinigte Staaten | 99 | 100,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Athena Countouriotis
- Persönliches Netzwerk
